[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Pages 3173-3174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01082]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the Task Force on
Research Specific to Pregnant Women and Lactating Women.
The meetings will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Task Force on Research Specific to Pregnant
Women and Lactating Women.
Date: February 26-27, 2018.
Time: February 26, 2018, 8:30 a.m. to 5:00 p.m.; February 27, 2018,
8:00 a.m. to 3:00 p.m.
Agenda: The Task Force is charged with providing advice and
guidance to the Secretary of HHS, regarding Federal activities related
to identifying and addressing gaps in knowledge and research regarding
safe and effective therapies for pregnant women and lactating women,
including the development of such therapies and the collaboration on
and coordination of such activities.
February 26th, 2018--Day 1
8:30 a.m.--Welcome and Opening Remarks
8:40 a.m.--Introductions
8:45 a.m.--Summary and Discussion of work products from meetings 1 and
2
10:45 a.m.--Follow-up on Task Force Request regarding Lessons learned
from Pediatrics
1:15 p.m.--Effective communication strategies with health care
providers and the public on information relevant to pregnant women and
lactating women
1:50 p.m.--Panel: Effective communication strategies with health care
providers on information relevant to pregnant women and lactating women
3:30 p.m.--Panel: Effective communication strategies with the public on
information relevant to pregnant women and lactating women.
4:10 p.m.--Discussion
5:00 p.m.--End of Day 1
February 27th, 2018--Day 2
8:00 a.m.--Recap from Day 1, Outline & Goals of Day 2
8:15 a.m.--Panel and open discussion to cover specific questions on the
options for a plan or plans to identify and address gaps in knowledge
and research regarding safe and effective therapies for pregnant women
and lactating women, including the development of such therapies.
12:45 p.m.--Discussion of Key Points related to topic: Effective
communication strategies with health care providers and the public on
information relevant to pregnant women and lactating women
1:30 p.m.--Discussion of Key Points related to topic: A plan to
identify and address gaps in knowledge and research regarding safe and
effective therapies for pregnant women and lactating women, including
the development of such therapies
2:15 p.m.--Review of Recommendations from TF1-3
2:45 p.m.--Action Items, Charge to Group
3:00 p.m.--Adjournment
Place: 6710B Rockledge Drive, Room 1425/1427 (1st Floor), Bethesda,
MD 20817.
Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice
Kennedy Shriver National Institute of Child Health and Human
Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD 20892,
(301) 496-0536, [email protected].
Public comments are welcome either by filing written comments and/
or providing oral comments at the meeting. Oral comments from the
public will be scheduled on February 26, 2018, from approximately 10:00
a.m.-10:45 a.m. Any member of the public interested in presenting oral
comments on February 26, 2018, should submit a letter of intent, a
brief description of the organization represented, and the oral
presentation to Ms. Lisa Kaeser ([email protected]) by 5:00 p.m. on
Monday, February 19, 2018. Written
[[Page 3174]]
comments to be included at the meeting should also be sent to Lisa
Kaeser by 5:00 p.m. on Monday, February 19, 2018.
The submitted presentations and any written comments will be
formatted to be posted on the PRGLAC website for the record. Only one
representative of an organization may be allowed to present oral
comments. Presentations will be limited to three to five minutes per
speaker depending on the number of speakers to be accommodated within
the allotted time. Speakers will be assigned a time to speak in the
order of the date and time when their request to speak is received.
Both printed and electronic copies are requested for the record.
Details and additional information about these meetings can be
found at the NICHD website for the Task Force on Research Specific to
Pregnant Women and Lactating Women (PRGLAC) https://www.nichd.nih.gov/about/advisory/PRGLAC/Pages/index.aspx.
Dated: January 17, 2018.
Michelle Trout,
Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-01082 Filed 1-22-18; 8:45 am]
BILLING CODE 4140-01-P